Nexgel 

$0.4551
18
-$0.01-2.96% 18:53 Today

Statistics

Day High
0.4664
Day Low
0.4501
52W High
2.89
52W Low
0.4501
Volume
1,287,480
Avg. Volume
-
Mkt Cap
4.2M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.13
-0.11
-0.09
-0.07
Expected EPS
-0.12
Actual EPS
N/A

Financials

-26.27%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
11.42MRevenue
-3MNet Income

Analyst Ratings

2.00Average Price Target
The highest estimate is 2.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXGL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its subsidiary companies, produces a variety of healthcare products that compete directly with Nexgel's wound care and gel products.
3M
MMM
Mkt Cap82.16B
3M operates in the healthcare segment offering medical products that include wound care solutions, competing with Nexgel's offerings.
Stryker
SYK
Mkt Cap126.42B
Stryker Corporation offers a range of medical technologies, including wound management and surgical products that can compete with Nexgel's advanced healing solutions.
Medtronic
MDT
Mkt Cap107.36B
Medtronic plc provides medical technologies, services, and solutions, including wound care and patient monitoring systems that compete with Nexgel's product line.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with Nexgel in the wound care market.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including wound care solutions that compete with Nexgel.
Baxter International
BAX
Mkt Cap11.68B
Baxter International Inc. provides a portfolio of healthcare products, including advanced recovery and wound care products, directly competing with Nexgel's offerings.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; and wound care and related products that compete with Nexgel.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical, Inc. develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, indirectly competing with Nexgel's wound healing solutions.

About

NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Show more...
CEO
Mr. Adam R. Levy
Employees
19
Country
United States
ISIN
US65344E1073

Listings

0 Comments

Share your thoughts

FAQ

What is Nexgel stock price today?
The current price of NXGL is $0.46 USD — it has decreased by -2.96% in the past 24 hours. Watch Nexgel stock price performance more closely on the chart.
What is Nexgel stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Nexgel stocks are traded under the ticker NXGL.
Is Nexgel stock price growing?
NXGL stock has fallen by -11.2% compared to the previous week, the month change is a -15.21% fall, over the last year Nexgel has showed a -81.93% decrease.
What is Nexgel market cap?
Today Nexgel has the market capitalization of 4.2M
When is the next Nexgel earnings date?
Nexgel is going to release the next earnings report on August 18, 2026.
What were Nexgel earnings last quarter?
NXGL earnings for the last quarter are -0.11 USD per share, whereas the estimation was -0.07 USD resulting in a -57.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nexgel revenue for the last year?
Nexgel revenue for the last year amounts to 11.42M USD.
What is Nexgel net income for the last year?
NXGL net income for the last year is -3M USD.
How many employees does Nexgel have?
As of July 15, 2026, the company has 19 employees.
In which sector is Nexgel located?
Nexgel operates in the Health & Wellness sector.
When did Nexgel complete a stock split?
Nexgel has not had any recent stock splits.
Where is Nexgel headquartered?
Nexgel is headquartered in Langhorne, United States.